Literature DB >> 1087347

Suppressor factor secreted by T-lymphocytes from tumor-bearing mice.

A J Treves, I R Cohen, M Feldman.   

Abstract

Spleen cells from C57BL mice bearing the syngeneic carcinoma 3LL enhanced tumor growth. Tumor growth was also enhanced by a soluble factor found in the media of cultured spleen cells from tumor-bearing animals. This factor suppressed a protective immune response of the host and was found to be a product of T-lymphocytes. Removal of B-lymphocytes and macrophages did not prevent its appearance in the culture media, whereas removal of T-lymphocytes inhibited its appearance. Similar suppressor factors were obtained from C3H mice bearing the 3LL tumor and from mice with other tumors. The suppressing factor produced after the growth of 3LL tumor also enhanced the growth of other tumors. It could act on strains incompatible with the donor of the factor-producing cells. Hence tumor growth was possibly facilitated by soluble products of T-lymphocytes that were found in spleens of tumor-bearing mice and that nonspecifically suppressed immune defense mechanisms.

Entities:  

Mesh:

Year:  1976        PMID: 1087347     DOI: 10.1093/jnci/57.2.409

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

1.  A T-dependent factor in mouse serum suppressing lymphocytic anti-tumor cytotoxicity.

Authors:  P E Rao; D H Sussdorf
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

2.  Spinal leptomeningeal epidermoid cysts in inbred mouse strains.

Authors:  W G Stroop
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

3.  Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Factors inducing a loss of net negative surface charge on spleen cells of mice grafted with a slow-growing tumour.

Authors:  D Vaillier; J Vaillier
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.